1. Kudo, I., Nojima, S., Chang, H.W., Yanoshita, R., Hayashi, H., Kondo, E., Nomura, H., and Inoue, K. (1987) Antitumor Activity of Synthetic Alkyl-Phospholipids With or Without PAF Activity, Lipids 22, 862–867.
2. Berdel, W.E., Korth, R., Reichert, A., Houlihan, W.J., Bicker, U., Nomura, H., Vogler, W.R., Benveniste, J., and Rastetter, J. (1987) Lack of Correlation Between Cytotoxicity of Agonists and Antagonists of Platelet Activating Factor (paf-acether) in Neoplastic Cells and Modulation of 3H-paf-Acether Binding to Platelets from Humans in vitro, Anticancer Res. 7, 1181–1187.
3. Berdel, W.E. (1991) Membrane-Interactive Lipids as Experimental Anticancer Drugs, Br. J. Cancer 64, 208–211.
4. Andreesen, R. (1988) Ether Lipids in the Therapy of Cancer, Prog. Biochem. Pharmacol. 22, 118–131.
5. Daniel, L.W. (1991) Ether Lipids in Experimental Cancer Chemotherapy, in Cancer Chemotherapy (Hickman, J.A., and T.R. Tritton, eds.) pp. 146–178, Blackwell Scientific Publications, Ltd., Oxford.